Wang Erik F, Jotwani Rohan
Department of Anesthesiology, Weill Cornell Medicine/NewYork-Presbyterian, New York, NY, USA.
Department of Anesthesiology, Weill Cornell Medicine, New York, NY, USA.
Interv Pain Med. 2023 Feb 24;2(1):100181. doi: 10.1016/j.inpm.2023.100181. eCollection 2023 Mar.
Myofascial pain syndrome (MPS) is a highly prevalent and burdensome cause of pain globally, representing a major focus of chronic pain management. Management of MPS is highly variable, with therapies ranging from interventional approaches to physical therapy. Virtual reality (VR) is a novel form of therapy being actively explored as an adjuvant to procedural sedation in the acute pain setting, and increasingly as a means of chronic pain management through programs that facilitate pain education, physical therapy and mindfulness, among other approaches. However, to date, there are minimal clinical studies assessing VR therapy within the context of MPS treatments. Given the existing volume of work published in the acute pain setting and the translational work exploring VR and neuroplasticity in chronic pain, we make the case here that it is an appropriate time to consider exploring VR therapy as a non-pharmacological adjuvant treatment for MPS.
肌筋膜疼痛综合征(MPS)是全球范围内一种高度普遍且负担沉重的疼痛原因,是慢性疼痛管理的主要关注点。MPS的管理方式差异很大,治疗方法从介入性方法到物理治疗不等。虚拟现实(VR)是一种新型治疗形式,正在急性疼痛环境中作为程序镇静的辅助手段积极探索,并且越来越多地作为慢性疼痛管理的一种手段,通过促进疼痛教育、物理治疗和正念等项目来实现。然而,迄今为止,在MPS治疗背景下评估VR治疗的临床研究极少。鉴于在急性疼痛环境中已发表的现有工作量以及在慢性疼痛中探索VR与神经可塑性的转化研究,我们在此提出,现在是考虑将VR治疗作为MPS的非药物辅助治疗进行探索的适当时机。